Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 6 hours ago

      Novo Nordisk responded today to the U.S. Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. The Ozempic maker denied wrongdoing ...